Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics, and patterns of care among Indigenous and non-indigenous cancer patients, Queensland, Australia 19982004

From: Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients

  Indigenous (n = 956) N (%) Non-Indigenous (n = 869) N (%) P-value
Age    
18- 39 years 108 (11) 91 (11) 0.852
40 – 59 years 421 (44) 387 (45)
60 + years 427 (45) 391 (45)
Sex    
male 436 (46) 393 (45) 0.870
female 520 (54) 476 (55)
Area of remoteness index    
Highly accessible/Accessible 329 (34) 369 (43) <0.001
Moderately accessible 370 (39) 325 (37)
Remote/Highly remote 257 (27) 175 (20)
Socioeconomic status (SEIFA)    
1 Most disadvantaged 354 (37) 215 (25) <0.001
2 Disadvantaged 238 (25) 261 (30)
3 Intermediate advantage 213 (22) 219 (25)
4 Advantaged 111 (12) 136 (16)
5 Most advantaged 39 (4) 36 (4)
Cancer stage at diagnosis*    
Localised cancer 316 (38) 336 (45) 0.030
Regional Spread 240 (29) 197 (26)
Distant metastasis 275 (33) 221 (29)
Unknown or not applicable 125 115  
Comorbidity score**    
0 481 (50) 601 (69) <0.001
1 256 (27) 143 (16)
2+ 219 (23) 125 (14)
Diabetes    
No 669 (70) 785 (90) <0.001
Yes 287 (30) 84 (10)
HbA1C levels recorded (N = 113) (N = 18)  
Equal to or less than 6.5% 36 (32) 7 (39) 0.485
Greater than 6.5% 77 (68) 11 (61)
Any cancer treatment    
Given treatment 716 (75) 745 (86) <0.001
No treatment or treatment unknown 240 (25) 124 (14)
Curative cancer treatment £ N=556 N=533  
Given treatment 400(72) 417 (78) 0.030
No treatment or treatment unknown 153 (28) 116 (22)
Surgery    
Surgery 494 (52) 549 (64) <0.001
No surgery or treatment unknown 462 (48) 320 (36)
Chemotherapy    
Chemotherapy 269 (28) 321 (37) <0.001
No chemotherapy or treatment unknown 687 (72) 548 (63)
Chemotherapy completed ^ N=160 N=190  
Completed 122 (76) 152 (80) 0.530
Not completed or treatment unknown 38 (24) 38 (20)
Radiotherapy    
Radiotherapy 325 (34) 359 (41) 0.001
No Radiotherapy or not sure 631 (66) 510 (59)
Age    
18- 39 years 108 (11) 91 (11) 0.852
40 – 59 years 421 (44) 387 (45)
60 + years 427 (45) 391 (45)
Sex    
male 436 (46) 393 (45) 0.870
female 520 (54) 476 (55)
Area of remoteness index    
Highly accessible/Accessible 329 (34) 369 (43) <0.001
Moderately accessible 370 (39) 325 (37)
Remote/Highly remote 257 (27) 175 (20)
Socioeconomic status ( SEIFA )    
1 Most disadvantaged 354 (37) 215 (25) <0.001
2 Disadvantaged 238 (25) 261 (30)
3 Intermediate advantage 213 (22) 219 (25)
4 Advantaged 111 (12) 136 (16)
5 Most advantaged 39 (4) 36 (4)
Cancer site and IDC code #    
Bronchus and lung (C33- C34) 187 (20) 173 (20) 0.9
Breast (C56) 111 (12) 107 (12)
Colorectal and small intestine (C17-20) 87 (9) 89 (10)
Head and neck (C00- C14) 83 (9) 84 (10)
Lymphoma and leukaemia (C42 & C77/ M 01- M10) 61 (6) 55 (6)
Cervix (C53) 56 (6) 49 (6)
Liver (C22) 48 (5) 30 (4)
Other cancers 41 (4) 32 (4)
Renal tract (C64- C67) 40 (4) 46 (5)
Corpus uteri (C54) 38 (4) 36 (4)
Oesophagus (C15) 31 (3) 21 (2)
Other cancers 47 (5) 35 (4)
Ovary (C56) 29 (3) 29 (3)
Unknown primary (C80) 29 (3) 17 (2)
Stomach (16) 27 (3) 23 (3)
Prostate (C61) 25 (3) 17 (2)
Pancreas (C25) 22 (2) 25 (3)
Thyroid (C73) 21 (2) 14 (2)
Central Nervous System (C71) 13 (1) 12 (1)
Melanoma (C44 or M12)) 7 (1) 10 (1)
Cancer stage at diagnosis*    
Localised cancer 316 (38) 336 (45) 0.030
Regional Spread 240 (29) 197 (26)
Distant metastasis 275 (33) 221 (29)
Unknown or not applicable 125 115  
Comorbidity score**    
0 481 (50) 601 (69) <0.001
1 256 (27) 143 (16)
2+ 219 (23) 125 (14)
Diabetes    
No 669 (70) 785 (90) <0.001
Yes 287 (30) 84 (10)
HbA1C levels recorded (N = 113) (N = 18)  
Equal to or less than 6.5% 36 (32) 7 (39) 0.485
Greater than 6.5% 77 (68) 11 (61)
Any cancer treatment    
Given treatment 716 (75) 745 (86) <0.001
No treatment or treatment unknown 240 (25) 124 (14)
Curative cancer treatment £ N=556 N=533  
Given treatment 400 (72) 417 (78) 0.030
No treatment or treatment unknown 153 (28) 116 (22)
Surgery    
Surgery 494 (52) 549 (64) <0.001
No surgery or treatment unknown 462 (48) 320 (36)
Chemotherapy    
Chemotherapy 269 (28) 321 (37) <0.001
No chemotherapy or treatment unknown 687 (72) 548 (63)
Chemotherapy completed ^ N=160 N=190  
Completed 122 (76) 152 (80) 0.530
Not completed or treatment unknown 38 (24) 38 (20)
Radiotherapy    
Radiotherapy 325 (34) 359 (41) 0.001
No Radiotherapy or treatment unknown 631 (66) 510 (59)
  1. #International Classification of Diseases 10th Revision (ICD-10-AM) code.
  2. *Cases with missing data not included in analysis but numbers presented for completeness.
  3. **Charlson Comorbidity Index: scores 2–5 and 5+ were grouped.
  4. £Includes cases with localised and regional stage disease only.
  5. ^Includes only cases with non-metastatic disease who received chemotherapy.